Use of haptoglobin to prevent renal damage due to hemolysis in extensive third-degree burns

Journal of Burn Care and Rehabilitation

Volumn 5, Issue 1, 1984, Pages 20-24

  Aikawa, N ^a,b   Ishibiki, K ^a,b   Okusawa, S ^a,b   Yamamoto, S ^a,b   Motegi, M ^a,b   Sudo, M ^a,b   Abe, O ^a,b  

^a KEIO UNIVERSITY   (Japan)

^b Saiseikai Kanagawaken Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HAPTOGLOBIN;

BLOOD AND HEMOPOIETIC SYSTEM; BURN; CLINICAL ARTICLE; DRUG THERAPY; HEMOLYSIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY; KIDNEY FAILURE; KIDNEY INJURY; PREVENTION; THERAPY;

EID: 0021322941     PISSN: 02738481     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004630-198401000-00017     Document Type: Article

References (17)

1. Laurell CB, Nyman M: Studies on the serum haptoglobin level in hemoglobinemia and its influence on renal excretion of hemoglobin. Blood 12:493–506, 1957.
2. Allison AC: The binding of haemoglobin by plasma proteins (haptoglobins). Br Med J 2:1137–1145, 1957.
3. Lathem W: The renal excretion of hemoglobin: Regulatory mechanisms and the differential excretion of free and protein-bound hemoglobin. J Clin Invest 38:652–658, 1959.
4. Myers JK, Storrs D, Miller TB, et al: The role of renal tubular flow in the pathogenesis of traumatic renal failure. Surg Gynecol Obstet 123:1243–1251, 1966.
5. Aikawa N, Martyn JAJ, Burke JF: Pulmonary artery catheterization and thermodilution cardiac output determination in the management of critically burned patients. Am J Surg 135:811–817, 1978.
6. Aikawa N, Ishibiki K, Naito C, et al: Individualized fluid resuscitation based on haemodynamic monitoring in the management of extensive burns. Burns 8:249–255, 1982.
7. Mancini G, Carbonara AO, Henemans JF: Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 2:235–254, 1965.
8. Kampen EJ, Zijlstra, WG: Standardization of hemoglobinometry. II. The hemoglobincyanide method. Clin Chim Acta 6:538–544, 1961.
9. Funakoshi S, Oomura T, Ohshiro T, et al: Haptoglobin: Its isolation and clinical significance, in Trace Components of Plasma: Isolation and Clinical Significance. New York, Alan R. Liss Inc, 1976, pp 397–410.
10. ENa test; use in the differential diagnosis of acute renal failure. JAMA 236:579–581, 1976.
11. Nyman M: Serum haptoglobin. Scand J Clin Lab Invest lKsuppl 391:1–169, 1959.
12. Mason AD Jr, Alexander JW, Teschan PE: Studies in acute renal failure. I. Development of a reproducible lesion in experimental animals. J Surg Res 9:430–441, 1963.
13. Ukai T, Shida I, Shin J, et al: Use of human haptoglobin for the prophylaxis of acute renal failure in the severely burned patients. Jpn J Burn Inj 1:209–216, 1976.
14. Ohshira T, Yoshioka T, Ukai T: The prevention of hemolytic renal failure by haptoglobin administration. Saishinigaku 30:2238–2246, 1975.
15. Homann B, Weis KH, Kult J: Behandlung eines ABO-bedingten haemolytischen Transfusionszwischenfalls mit Haptoglobinkonzentrat. Dtsch Med Wochenschr 102(21):810–811, 1977.
16. Nagara H, Atobe M, Hiratsuka H, et al: Administration of haptoglobin in open heart surgery; prevention of hemoglobinuria. Jpn J Soc Thorac Surg 27:257–262, 1979.
17. Matsuda J, Abe T: Effects of haptoglobin concentration on transfusion in autoimmune hemolytic anemia. Clin Immunol 11:215–222, 1979.